Current report filing

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.20.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
5 Months Ended 7 Months Ended 12 Months Ended
Mar. 31, 2020
Oct. 31, 2019
Mar. 31, 2019
Mar. 31, 2018
Cash flows from operating activities:        
Net income (loss) $ 139,076 $ (836,206) $ (336,138) $ (197,109)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 43,741 70,864 124,899 124,042
Deferred income taxes (4,866) (62,476) (14,454) (49,334)
Write off of deferred financing fees 0 4,038 0 2,969
Discount amortization on long-term debt 5,890 1,563 6,337 1,701
Reorganization items, net (16,254) 552,304 0 0
Loss on disposal of assets 451 3,768 27,843 17,595
Loss on impairment 9,591 62,101 117,220 91,400
Loss on sale of subsidiaries 0 55,883 0 0
Deferral of lease payments 0 285 5,094 3,991
Beneficial conversion feature on DIP Loan 0 56,870 0 0
DIP Claim Liability 0 15,000 0 0
Change in fair value of preferred stock derivative liability (184,140) 0 0 0
Stock-based compensation 2,412 1,871 6,382 10,436
Equity in earnings from unconsolidated affiliates less than (in excess of) dividends received (1,184) (1,776) 3,806 (4,754)
Increase (decrease) in cash resulting from changes in:        
Accounts receivable 24,097 (10,247) 19,197 (32,459)
Inventories (2,856) (605) (7,473) (2,154)
Prepaid expenses and other assets (483) (1,226) 1,543 11,913
Accounts payable (15,823) (13,861) 4,487 (3,385)
Accrued liabilities (3,966) 23,745 (55,058) 6,070
Other liabilities and deferred credits (5,199) (20,761) (13,122) (466)
Net cash used in operating activities (9,513) (98,866) (109,437) (19,544)
Cash flows from investing activities:        
Capital expenditures (36,115) (41,574) (40,902) (46,287)
Deposits on assets held for sale 4,500 0 0 0
Proceeds from asset dispositions 13,845 5,314 13,813 48,740
Proceed from sale of consolidated affiliate 0 0 965 0
Proceeds from OEM cost recoveries 0 0 0 94,463
Cash transferred in sale of subsidiaries, net of cash received 0 (22,458) 0 0
Net cash provided by (used in) investing activities (17,770) (58,718) (26,124) 96,916
Cash flows from financing activities:        
Proceeds from borrowings 0 225,585 470 896,874
Debt issuance costs 0 (14,863) (2,599) (20,560)
Repayment of debt and debt redemption premiums (25,132) (366,750) (61,052) (671,567)
Purchase of 4.5% Convertible Senior Notes call option 0 0 0 (40,393)
Proceeds from issuance of warrants 0 0 0 30,259
Partial prepayment of put/call obligation 0 (1,323) (54) (49)
Dividends paid to noncontrolling interest 0 0 (580) (331)
Common stock dividends paid 0 0 0 (2,465)
Issuance of common stock 0 385,000 2,830 0
Repurchases for tax withholdings on vesting of equity awards 0 0 (2,157) (2,740)
Net cash provided by (used in) financing activities (25,132) 227,649 (63,142) 189,028
Effect of exchange rate changes on cash, cash equivalents and restricted cash 1,010 2,406 (3,465) 17,167
Net increase (decrease) in cash, cash equivalents and restricted cash (51,405) 72,471 (202,168) 283,567
Cash, cash equivalents and restricted cash at beginning of period 250,526 178,055 380,223 96,656
Cash, cash equivalents and restricted cash at end of period $ 199,121 $ 250,526 $ 178,055 $ 380,223